Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e7198340cbf897c1bd2a422117c6360 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 |
filingDate |
2010-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d83d3ee64d3370058f52ee4ed235c1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9682a3bcab11091ca2a7ac02fa5b7585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24389ccf17b9abd98f7be9b99d5343e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e70e46a7a89548818332ba99df721f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a4c7568b6a54348c52ba594db003a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a969407430b096d0ce6bdf4ad89a0373 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51100f20c850a58d2172b9d1b83c6272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf81f05d3521312b4985081257163654 |
publicationDate |
2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2389169-A1 |
titleOfInvention |
Controlled release formulations with continuous efficacy |
abstract |
The present invention relates to pharmaceutical compositions, which provide controlled release of a drug. The compositions are suitable for continuous administration as they remain effective throughout the treatment regimen. The present invention also relates to the use of the compositions for preparation of a medicament for continuous treatment of an individual. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632201-B2 |
priorityDate |
2009-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |